- Home
- PBHC vs ANIX Comparison
PBHC vs ANIX Comparison
Compare PBHC & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBHC
- ANIX
- Stock Information
- Founded
- PBHC 1859
- ANIX 1982
- Country
- PBHC United States
- ANIX United States
- Employees
- PBHC N/A
- ANIX N/A
- Industry
- PBHC Major Banks
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- PBHC Finance
- ANIX Health Care
- Exchange
- PBHC Nasdaq
- ANIX Nasdaq
- Market Cap
- PBHC 93.1M
- ANIX 95.7M
- IPO Year
- PBHC N/A
- ANIX 1987
- Fundamental
- Price
- PBHC N/A
- ANIX $4.44
- Analyst Decision
- PBHC
- ANIX Strong Buy
- Analyst Count
- PBHC 0
- ANIX 3
- Target Price
- PBHC N/A
- ANIX $9.00
- AVG Volume (30 Days)
- PBHC 3.4K
- ANIX 216.1K
- Earning Date
- PBHC 10-29-2025
- ANIX 09-10-2025
- Dividend Yield
- PBHC 2.60%
- ANIX N/A
- EPS Growth
- PBHC N/A
- ANIX N/A
- EPS
- PBHC 0.28
- ANIX N/A
- Revenue
- PBHC $39,015,000.00
- ANIX N/A
- Revenue This Year
- PBHC N/A
- ANIX N/A
- Revenue Next Year
- PBHC N/A
- ANIX N/A
- P/E Ratio
- PBHC $54.80
- ANIX N/A
- Revenue Growth
- PBHC N/A
- ANIX N/A
- 52 Week Low
- PBHC $13.55
- ANIX $2.07
- 52 Week High
- PBHC $19.86
- ANIX $4.49
- Technical
- Relative Strength Index (RSI)
- PBHC N/A
- ANIX 75.87
- Support Level
- PBHC N/A
- ANIX $3.21
- Resistance Level
- PBHC N/A
- ANIX $3.44
- Average True Range (ATR)
- PBHC 0.00
- ANIX 0.18
- MACD
- PBHC 0.00
- ANIX 0.06
- Stochastic Oscillator
- PBHC 0.00
- ANIX 87.76
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.